TMEM14C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.711600E-01
Normal-vs-Stage2
9.960800E-01
Normal-vs-Stage3
8.299000E-01
Normal-vs-Stage4
4.781600E-01
Stage1-vs-Stage2
7.484600E-01
Stage1-vs-Stage3
9.173000E-01
Stage1-vs-Stage4
3.334600E-01
Stage2-vs-Stage3
6.751400E-01
Stage2-vs-Stage4
3.688600E-01
Stage3-vs-Stage4
3.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.692600E-01
Normal-vs-AfricanAmerican
7.654000E-01
Normal-vs-Asian
8.503800E-01
Caucasian-vs-AfricanAmerican
6.326600E-01
Caucasian-vs-Asian
7.612200E-01
AfricanAmerican-vs-Asian
4.824200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.233600E-01
Normal-vs-Female
9.588800E-01
Male-vs-Female
5.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.096200E-01
Normal-vs-Age(41-60Yrs)
9.849000E-01
Normal-vs-Age(61-80Yrs)
9.158200E-01
Normal-vs-Age(81-100Yrs)
4.480400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.229600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.785990E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.685500E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.866200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.194150E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.180400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.979000E-01
Normal-vs-Daily Drinker
7.777800E-01
Normal-vs-Weekly Drinker
8.976600E-01
Normal-vs-Occasional Drinker
9.217800E-01
Normal-vs-Social Drinker
8.124800E-01
Non Drinker-vs-Daily Drinker
6.022400E-01
Non Drinker-vs-Weekly Drinker
7.372000E-01
Non Drinker-vs-Occasional Drinker
8.632000E-01
Non Drinker-vs-Social Drinker
7.222800E-01
Daily Drinker-vs-Weekly Drinker
7.415000E-01
Daily Drinker-vs-Occasional Drinker
4.328800E-01
Daily Drinker-vs-Social Drinker
8.047600E-01
Weekly Drinker-vs-Occasional Drinker
5.420600E-01
Weekly Drinker-vs-Social Drinker
9.588000E-01
Occasional Drinker-vs-Social Drinker
5.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.996810E-01
Normal-vs-Grade 2
3.020400E-02
Normal-vs-Grade 3
5.259600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.084060E-02
Grade 1-vs-Grade 3
9.906100E-02
Grade 1-vs-Grade 4
1.996810E-01
Grade 2-vs-Grade 3
3.779800E-01
Grade 2-vs-Grade 4
3.020400E-02
Grade 3-vs-Grade 4
5.259600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.252600E-01
Normal-vs-NonDiabetic
9.843600E-01
Diabetic-vs-NonDiabetic
5.198200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.146400E-01
Normal-vs-NoPancreatitis
9.231200E-01
Pancreatitis-vs-NoPancreatitis
5.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.926600E-01
Normal-vs-N1
9.842000E-01
N0-vs-N1
9.082400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.212600E-01
Normal-vs-TP53-NonMutant
6.110400E-01
TP53-Mutant-vs-TP53-NonMutant
4.004900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
